| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/06/2011 | US20110002877 PTEN Inhibitors Treat Neutropenia-Associated Pneumonia |
| 01/06/2011 | US20110002875 Method for treating amyloidosis |
| 01/06/2011 | US20110002854 Use of Francisella Tularensis For Prevention and Treatment of Allergic Airway Disorders |
| 01/06/2011 | US20110002851 Cationic Colloidal Carriers for Delivery of Active Agents to the Blood-Brain Barrier in the Course of Neuroinflammatory Diseases |
| 01/06/2011 | US20110002848 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 01/06/2011 | US20110002844 Stabilization of macromolecular membranes |
| 01/06/2011 | CA2770153A1 Improved formulations for nonsurgical exogenous crosslink therapy |
| 01/06/2011 | CA2767105A1 Methods of stimulating liver regeneration |
| 01/06/2011 | CA2767039A1 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes |
| 01/06/2011 | CA2767012A1 Dermaseptin b2 used as an inhibitor of the growth of a tumor |
| 01/06/2011 | CA2766162A1 Smac mimetic |
| 01/06/2011 | CA2765602A1 N-terminal truncated amyloid beta protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's disease |
| 01/06/2011 | CA2763692A1 Neurotoxins exhibiting shortened biological activity |
| 01/05/2011 | EP2270230A2 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 01/05/2011 | EP2270209A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/05/2011 | EP2270192A1 Glycopeptide antibiotics |
| 01/05/2011 | EP2270177A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270176A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270175A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270171A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 01/05/2011 | EP2270170A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/05/2011 | EP2270164A2 Recombinant protein variants |
| 01/05/2011 | EP2270163A1 Muteins of fibroblast growth factor 21 |
| 01/05/2011 | EP2270162A2 Conserved HBV and HCV sequences useful for gene silencing |
| 01/05/2011 | EP2270158A2 Bitter taste receptors |
| 01/05/2011 | EP2270157A2 Bitter taste receptors |
| 01/05/2011 | EP2270156A2 Bitter taste receptors |
| 01/05/2011 | EP2270155A2 Bitter taste receptors |
| 01/05/2011 | EP2270154A2 Bitter taste receptors |
| 01/05/2011 | EP2270153A2 Bitter taste receptors |
| 01/05/2011 | EP2270144A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof |
| 01/05/2011 | EP2270138A1 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes |
| 01/05/2011 | EP2270055A2 Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component |
| 01/05/2011 | EP2270052A2 Antibodies to OPGL |
| 01/05/2011 | EP2270047A2 Anti-C5 antibodies and their therapeutic uses |
| 01/05/2011 | EP2270046A2 Methods and compositions for the treatment of hemolysis-associated diseases |
| 01/05/2011 | EP2270042A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270041A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270040A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 01/05/2011 | EP2270038A2 GAG binding proteins |
| 01/05/2011 | EP2270037A2 Hasylated Factor IX |
| 01/05/2011 | EP2270036A2 Hasylated polypeptides |
| 01/05/2011 | EP2270035A2 Peptides enhancing CEH activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis |
| 01/05/2011 | EP2270031A2 Heterologous expression of neisserial proteins |
| 01/05/2011 | EP2270030A2 Heterologous expression of Neisserial proteins |
| 01/05/2011 | EP2270027A1 Polypeptides having brain-localizing activity and uses thereof |
| 01/05/2011 | EP2270026A2 Compounds for proteasome enzyme inhibition |
| 01/05/2011 | EP2270024A1 Antisense modulation of superoxide dismutase 1, soluble expression |
| 01/05/2011 | EP2270005A1 Prodrug of an ice inhibitor |
| 01/05/2011 | EP2270004A1 Caspase inhibitors and uses thereof |
| 01/05/2011 | EP2269980A1 Creatine amides, a method for the production thereof and an agent exhibiting a neuroprotective action |
| 01/05/2011 | EP2269658A1 Gene therapy for neurometabolic disorders |
| 01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 01/05/2011 | EP2269646A1 Prophylactic or therapeutic agent for diabetes or obesity |
| 01/05/2011 | EP2269635A1 Enterococcus antigens and vaccines |
| 01/05/2011 | EP2269631A2 Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics |
| 01/05/2011 | EP2269630A1 Novel anti-nematode therapies targetting STRM-1 |
| 01/05/2011 | EP2269629A2 Compositions and methods for producing antigen-presenting cells |
| 01/05/2011 | EP2269628A2 Pancreas-specific proteins |
| 01/05/2011 | EP2269627A1 Nodule specific medicago peptides having antimicrobial activity and pharmaceutical compositions containing the same |
| 01/05/2011 | EP2269626A2 Protective proteins of S. agalactiae, combinations thereof and methods of using the same |
| 01/05/2011 | EP2269625A2 Protective proteins of S. agalactiae, combinations thereof and methods of using the same |
| 01/05/2011 | EP2269624A2 Protective proteins of S. agalactiae, combinations thereof and methods of using the same |
| 01/05/2011 | EP2269623A1 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 01/05/2011 | EP2269622A1 CpG oligonucleotides used for enhancing steroid activity in a steroid dependent patient. |
| 01/05/2011 | EP2269619A1 Methods and compositions concerning poxviruses and cancer |
| 01/05/2011 | EP2269618A1 An oncolytic vaccinia virus for use in combination with a chemotherapy for treating cancer. |
| 01/05/2011 | EP2268807A2 Hyperglycosylated human coagulation factor ix |
| 01/05/2011 | EP2268673A2 Polypeptide-polymer conjugates and methods of use thereof |
| 01/05/2011 | EP2268666A1 Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation |
| 01/05/2011 | EP2268665A1 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity |
| 01/05/2011 | EP2268660A1 Anti-lps factor from parietaria judaica and methods of use thereof |
| 01/05/2011 | EP2268657A2 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 01/05/2011 | EP2268312A2 Treatment of intervertebral disc degeneration |
| 01/05/2011 | EP2268304A2 Methods for treating acute myocardial infarction |
| 01/05/2011 | EP2268303A1 NOVEL USES OF VEGF xxxB |
| 01/05/2011 | EP2268302A2 Bmp-7 for use in treating vascular sclerosis |
| 01/05/2011 | EP2268301A2 Erythropoietin and fibronectin compositions for bone regeneration |
| 01/05/2011 | EP2268300A2 Methods for the inhibition of scarring |
| 01/05/2011 | EP2268299A1 Compositions and method for reducing scar formation in wound healing |
| 01/05/2011 | EP2268298A1 Novel gp96 derived peptides |
| 01/05/2011 | EP2268296A1 Compositions and method for the diagnosis, prevention and treament of alzeimer's disease |
| 01/05/2011 | EP2268288A2 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections |
| 01/05/2011 | EP2268279A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl¨-3-oxoisoindoline-4-yl}carboxamide |
| 01/05/2011 | EP2268267A2 Dry transglutaminase composition |
| 01/05/2011 | EP2170368B1 Liquid protein formulations comprising gdf-5 for use at elevated temperatures |
| 01/05/2011 | EP2016950B1 Pharmaceutical composition comprising an exendin-4 peptide |
| 01/05/2011 | EP1922334B1 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
| 01/05/2011 | EP1912999B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/05/2011 | EP1750667B1 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 01/05/2011 | EP1745064B1 Compounds for proteasome enzyme inhibition |
| 01/05/2011 | EP1725233B1 Pharmaceutical composition comprising sns-595 and uses thereof |
| 01/05/2011 | EP1723417B1 C20orf23 as modifier of the igfr pathway and methods of use |
| 01/05/2011 | EP1623718B1 Skin collagen production promoter |
| 01/05/2011 | EP1619498B1 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
| 01/05/2011 | EP1549336B1 Prevention and/or treatment of ulcerative colitis using pyy or pyy[3-36] |
| 01/05/2011 | EP1546182B1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/05/2011 | EP1493034B1 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 01/05/2011 | EP1482964B1 Use of egfr transactivation inhibitors in human cancer |
| 01/05/2011 | EP1463806B1 Novel cyclooxygenase variants and methods of use |